In vitro Modulation of the LPS-Induced Proinflammatory Profile of Hepatocytes and Macrophages- Approaches for Intervention in Obesity? by Ramiar K. Kheder et al.
ORIGINAL RESEARCH
published: 22 June 2016
doi: 10.3389/fcell.2016.00061
Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 June 2016 | Volume 4 | Article 61
Edited by:
Carolina Henritta Pohl,
University of the Free State,
South Africa
Reviewed by:
Vishal Diwan,
University of Otago, New Zealand
Fabien Gosselet,
Artois University, France
*Correspondence:
Cordula M. Stover
cms13@le.ac.uk
Specialty section:
This article was submitted to
Lipidology,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 11 March 2016
Accepted: 07 June 2016
Published: 22 June 2016
Citation:
Kheder RK, Hobkirk J and Stover CM
(2016) In vitro Modulation of the
LPS-Induced Proinflammatory Profile
of Hepatocytes and Macrophages-
Approaches for Intervention in
Obesity?. Front. Cell Dev. Biol. 4:61.
doi: 10.3389/fcell.2016.00061
In vitro Modulation of the
LPS-Induced Proinflammatory Profile
of Hepatocytes and Macrophages-
Approaches for Intervention in
Obesity?
Ramiar K. Kheder 1, 2, James Hobkirk 3 and Cordula M. Stover 1*
1Department of Infection, Immunity, and Inflammation, University of Leicester, Leicester, UK, 2College of Nursing, University
of Raparin, Ranya, Iraq, 3Department of Sport, Health, and Exercise Science, University of Hull, Hull, UK
Low grade endotoxemia is a feature of obesity which is linked to development of
steatohepatitis in non-alcoholic fatty liver disease. In this study, macrophages (J774) and
hepatocytes (HepG2) were stimulated with lipopolysaccharide (LPS) from E. coli 0111:
B4 and analyzed for modulation of this response when preconditioned or stimulated
subsequent to LPS, with different doses of Vitamin D3 or docosahexaenoic acid (DHA)
over a time period of 1 and 5 days. Pro-inflammatory TNFα and pro-fibrotic TGFβ
released into the supernatants were measured by ELISA; qPCR was performed for
Srebp-1c and PPARα mRNA (genes for products involved in fatty acid synthesis and
catabolism, respectively). Vitamin D3 and DHA exerted a consistent, dose dependent
anti-inflammatory effect, and increased PPARα relative to Srebp-1c in both cell types. By
contrast, addition of free fatty acids (FFA, oleic acid/palmitic acid 2:1) caused aggravation
of LPS-induced inflammatory reaction and an increase of Srebp-1c relative to PPARα.
Our results argue in favor of dietary supplementation of Vitamin D3 or DHA (and avoidance
of monounsaturated/saturated fatty acids) to alleviate development of fatty liver disease.
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INTRODUCTION
Low grade endotoxemia has been detected in circumstances as diverse as a bolus of high fat diet
(Erridge et al., 2007), hemodialysis (Terawaki et al., 2010), and surgery (Fujita et al., 2003). Drained
via the portal vein, abdominally derived endotoxin, a pathogen associatedmolecular pattern, PAMP,
directly stimulates the reticuloendothelial system of the liver but also hepatocytes. Obesity, from
which insulin resistance develops, is linked to increased translocation of endotoxins from the gut
(Brun et al., 2007). Steatosis is the accumulation of fat in hepatocytes which can lead to an overall
increase in liver size, so-called hepatomegaly. Accumulation of lipids may lead to inflammation;
this is called non-alcoholic steatohepatitis, to differentiate the disease from alcohol-induced liver
injury, either of which can progress to cirrhosis. It is estimated that there is evidence of non-
alcoholic steatohepatitis in up to a third of populations in the developed world (Preiss and Sattar,
2008). Because of increasing prevalence of obesity in these populations, fatty liver disease has
recently become a pediatric diagnosis (Giorgio et al., 2013). Bacterial overgrowth, increased gut
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permeability and intestinal dysmotility are characteristics of
patients with non-alcoholic fatty liver disease (NAFLD) and non-
alcoholic steatohepatitis (NASH). Endotoxin levels were elevated
in patients diagnosed with NAFLD compared to control subjects
(Harte et al., 2010). One approach of modulating hepatic disease
activity is to target the microbiome (Zhu et al., 2014), but another
might be to modulate the effects of bacterial lipopolysaccharide
(LPS) on hepatic cells, which express its receptor, TLR4 (Sharifnia
et al., 2015). Of note, circulating free fatty acids may also function
as endogenous ligands for TLR binding as so-called danger
associated molecular patterns, DAMPs.
Vitamin D3 and docosahexaenoic acid (an omega 3 fatty acid)
offer promise for the adjuvant treatment of NAFLD (Nobili et al.,
2011; Eliades and Spyrou, 2015). In fact, Vitamin D3 deficiency
has been found in patients with NAFLD, and omega 3 fatty
acid deficiency is associated with the development of insulin
resistance, fatty liver disease, and dyslipidemia (Targher et al.,
2013).
Therefore, the aim of this study was to expose macrophages
and hepatocytes to LPS and to gauge preventative or curative
effects of Vitamin D3 and docosahexaenoic acid (DHA) in vitro
while quantifying a detrimental effect of FFA, a mixture of oleic
acid and palmitic acid. Reactions were assessed by measuring
TNFα and TGFβ in supernatants of cells for which mRNA
expressions for Srebp-1c and PPARαwere determined in parallel.
MATERIALS AND METHODS
Materials
LPS E. coli 0111:B4 was from Invivogen (Toulouse, France),
docosahexaenoic acid, oleic acid, and palmitic acid were
purchased from Sigma-Aldrich Company Ltd. (Dorset, UK),
and Vitamin D3 was from DSM Nutritional products (Basel,
Switzerland).
Cell Culture
J774, a mouse macrophage cell line, and HepG2, a human
hepatocellular carcinoma cell line, were grown to semi confluence
at 37
◦
C in a humidified atmosphere (5% CO2) in RPMI 1640
medium or DMEM, respectively, supplemented with 10% (v/v)
fetal calf serum, 100 µg/ml streptomycin, 100 IU/ml penicillin.
They were passaged using trypsin EDTA. Cells were counted and
adjusted to 60,000/ml for J774, 40,000/ml for HepG2 in 25 cm2
flasks (5 ml) and treated when 70% confluent.
Experimental Design
The doses of Vitamin D3 (0.4, 2, 4 µg/ml) were chosen based on
a pilot experiment that investigated induction of insulin receptor
mRNA in target cells, a described, beneficial effect of Vitamin
D3 aimed at increasing insulin sensitivity (Maestro et al., 2000;
Supplementary Figure 1). DHAwas efficient at 50µM(16µg/ml)
to dampen the proinflammatory response of J774 induced by
LPS (100 ng/ml) after 5 days of stimulation (Oliver et al., 2012).
Doses of 8, 16, 32 µg/ml DHA were chosen for this work. The
composition of FFA was oleic acid/palmitic acid (2:1) and was
added at 15 and 30mM (Yao et al., 2011).
Two basic stimulation models were performed on HepG2 and
J774, namely, independently, preconditioning and subsequent
stimulation with LPS as well as initial stimulation with LPS and
post-hoc stimulation: In the preconditioning model, J774 and
HepG2 were exposed to different doses of Vitamin D3 (0.4, 2, 4
µg/ml), docosahexaenoic acid, DHA (8, 16, 32 µg/ml) or FFA,
free fatty acids (oleic acid/palmitic acid 2:1, 15, and 30 mM) prior
to stimulation with LPS E. coli 0111:B4 (100 ng/ml) for 24 h. In
the post-hoc stimulation model, J774 and HepG2 were exposed to
different doses of Vitamin D3 (0.4, 2, 4 µg/ml), docosahexaenoic
acid, DHA (8, 16, 32 µg/ml) or FFA, free fatty acids (oleic
acid/palmitic acid 2:1, 15, and 30mM) after stimulation with
LPS E. coli 0111:B4 (100 ng/ml) for 4 h. While Vitamin D3 and
DHA are protective agents, FFA simulates an obesity relevant
aggravating agent. Unstimulated controls were run in parallel.
cDNA Synthesis and qPCR
RNA was prepared using RNeasy Mini Kit (Qiagen, Manchester
UK), genomic DNA was digested and cDNA was synthesized
using RevertAid H Minus First Strand cDNA Synthesis
Kit (Thermo Fisher Scientific, Loughborough, UK). Primer
sequences are available in Supplementary Table 1. Their efficiency
was tested and sensitivity of amplification verified by linearity of
product yield vs. dilutions of cDNA. Real time PCR was used
to quantify the relative changes in gene expression by 2
−
11Ct
method using SYBR Green formulation and Corbett, Rotor gene
6000 real time rotary analyser. GAPDH mRNA expression was
found to be stable. Any variation was corrected by relating
expression of gene of interest to GAPDH mRNA expression of
the respective controls as part of the 2
−
11Ct method (Livak and
Schmittgen, 2001).
ELISA
ELISAs for mouse and human Transforming growth factor β,
TGFβ, were from R&D Systems (Abingdon, UK), ELISAs for
mouse and human Tumor necrosis factor α, TNFα, were from
PeproTech EC Ltd (London, UK). Supernatants were used neat
and assayed in triplicate. 3,3′,5,5′-Tetramethylbenzidine (TMB)
Liquid Substrate System was used.
Statistics
For ELISA measurements, standard curves were constructed
according to the manufacturers’ instructions and levels in
supernatants extrapolated using Graph Prism Pad. For qPCR
analyses, the data were presented as the fold change in gene
expression normalized to GAPDH and relative to unstimulated
control. Data from triplicate determinations were expressed
as means from averages ±SD. Unpaired one-way ANOVA
with Tukey’s multiple comparisons testing was performed and
adjusted p-values expressed.
RESULTS
J774 and HepG2 were used as model cells to investigate in
parallel the modulation of their LPS induced response by the
presence of Vitamin D3 and DHA using markers of relevance
in the inflammatory, profibrotic, and lipogenic response. Free
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Fatty Acids, FFA (oleic acid/palmitic acid 2:1), were used as a
stimulus to aggravate LPS-induced reactivity. A special focus was
to capture adaptation of the cells to long term corrective exposure
with Vitamin D3 or DHA before and after LPS stimulation
with a low endotoxin dose or the detrimental accumulating
effect of FFA when cells were exposed before or after the LPS
stimulus.
The dose of LPS E. coli 0111:B4 to model responses toward
low grade endotoxemia was compared in a pilot experiment
to a 10-fold higher dose. The dose of 1000 ng/ml was found
to negatively impact TLR and VDR mRNA expression in J774,
which behaved as acute sensors of the presence of this PAMP
in comparison with HepG2 (Supplementary Figure 2). The dose
of 100 ng/ml LPS has been used by others to study the anti-
inflammatory effect of DHA on macrophages (Mullen et al.,
2010). To determine that the dose of FFA was not toxic, a pilot
experiment investigated the effect of FFA on a morphological
feature of HepG2 cells, namely lipid accumulation. FFA was
found to enhance Oil Red O positive cell inclusions, which could
be reduced in the presence of Vitamin D3, whilst retaining cell
intactness (Supplementary Figure 3). DHA (50 µM) was shown
to have a similar effect on palmitate-induced lipids in HepG2
(Luo et al., 2012).
Benefical Effect of DHA and Vitamin D3 on
LPS-Induced TNFα and TGFβ Production
by Macrophages and Hepatocytes
A robust induction of TNFα production by 24 h stimulation with
LPS was observed in J774 and HepG2 (Figures 1A–D). There
was a significant and dose dependent reduction when parallel
cultures of J774 or HepG2 were preconditioned with varying
concentrations of Vitamin D3 (0.4, 2, 4 µg/ml) or DHA (8, 16, 32
µg/ml) for 1 or 5 days. Five days’ preconditioning with Vitamin
D3 (0.4, 2, 4 µg/ml) or DHA (8, 16, 32 µg/ml) before stimulation
with LPS was not more effective in reducing the inflammatory
gene response than preconditioning for 1 day only. The TNFα
response in J774 and HepG2 elicited by an acute 4 h-stimulation
with LPS was significantly reduced at 1 and 5 days of subsequent
incubation with Vitamin D3 or DHA at three different doses
each (Figures 1E–H). Macrophages at 5 days’ stimulation with
Vitamin D3 or DHA seemed particularly depressed in their TNFα
production (Figures 1E,G).
Analysis of the same supernatants for TGFβ showed that
Vitamin D3 and DHA significantly reduced TGFβ production
of J774 and HepG2 when preconditioned with these modulators
prior to LPS stimulation (Figures 2A–D). LPS led to a robust
production of TGFβ inmacrophages and hepatocytes. It is known
that LPS can trigger TGFβ production inmonocytes (Toossi et al.,
1996). Macrophages at 5 days’ stimulation with Vitamin D3 or
DHA seemed particularly depressed in their TGFβ production
(Figures 2A,C). Addition for 1 day and 5 days of higher doses
of Vitamin D3 (2, 4 µg/ml) or DHA (16, 32 µg/ml) prior to
the LPS stimulation reduced the production of TGFβ by HepG2
(Figures 2B,D). LPS-induced TGFβ production by J774 and
HepG2 cells was reduced in a dose dependent manner by the
subsequent addition of Vitamin D3 or DHA for 1 and 5 days
(Figures 2E–H). HepG2 seemed more sensitive to the action of
Vitamin D3 or DHA compared to J774.
Incubation with FFA elicited a dose dependent TNFα release
from J774 and HepG2 compared to basal levels (Figures 3A–D).
When preconditioned with FFA, macrophages showed a TNFα
response to subsequent LPS stimulation which was of the same
magnitude as LPS alone (Figure 3A). Stimulation with FFA
subsequent to LPS, however, led to an impaired TNFα response
(Figure 3C). In HepG2, stimulation with 30 mM FFA for 5 days
prior to LPS exposure, produced TNFα levels which were reduced
compared to those generated by LPS alone (Figure 3B), while
subsequent exposure with FFA after LPS stimulation further
increased TNFα secreted by HepG2 compared to LPS stimulated
cells (Figure 3D). Regarding TGFβ, the levels produced by J774
were highest after 5 days of either preconditioning of cells with
30 mM FFA before LPS stimulation, or post-hoc treatment of
cells with 30 mM FFA after LPS stimulation (Figures 3E,G). The
same observation was made for HepG2 cells: stimulation with 30
mM FFA for 5 days prior to LPS exposure, produced TGFβ levels
which exceeded those generated by LPS alone (Figure 3F), as did
post-hoc exposure with 30 mM FFA after LPS (Figure 3H).
Effect of DHA and Vitamin D3 on
LPS-Induced mRNA Expression of
Srepb-1c and PPARα by Macrophages and
Hepatocytes
LPS exposure of J774 and HepG2 stimulated Srebp-1c mRNA
expression (Figure 4) as expected (Costales et al., 2013).
Preconditioning of J774 for 1 day with Vitamin D3 led to a
dose dependent reduction of Srepb-1c mRNA, which was further
reduced after 5 days’ preconditioning. This means that 5 days
of incubation with a minimum dose of Vitamin D3 (0.4 µg/ml)
prevented the induction of Srepb-1c observed after addition of
100 ng/ml LPS for 24 h (Figure 4A). The same pattern was
observed for HepG2 cells, although higher doses of Vitamin
D3 (2, 4 µg/ml) were efficient after just 1 day of preconditioning
(Figure 4B). Preconditioning of J774 and HepG2 with DHA
for 5 days efficiently downregulated Srepb-1c mRNA with a
minimum dose studied of 8 µg/ml (Figures 4C,D). One day
prestimulation with 8µg/ml DHA significantly reduced Srepb-1c
mRNA in HepG2, while higher doses were necessary to achieve
this effect in J774 (Figures 4C,D). Exposure of LPS stimulated
J774 with Vitamin D3 or DHA yielded a dose dependent
reduction in Srepb-1c mRNA for both durations of incubation,
1 and 5 days (Figures 4E,G). Higher doses of Vitamin D3 (2,
4 µg/ml) were needed to maintain the reduction in Srepb-1c
mRNA observed at 1 day post-hoc stimulation compared to 5
days (Figure 4E). DHA, by contrast, significantly downregulated
Srepb-1c mRNA at 5 days’ incubation after LPS stimulation
compared to 1 day incubation (Figure 4G). In the presence
of Vitamin D3, LPS-induced Srepb-1c mRNA expression was
effectively downregulated at 1 and 5 days’ stimulation in HepG2
(Figure 4F), whereas higher doses of DHA had this effect at 5
days (Figure 4H).
An opposing pattern of stimulation is obtained when studying
PPARα mRNA expression (Figures 5A–H), whose translation
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FIGURE 1 | (A–H) TNFα response of J774 (A,C,E,G) and HepG2 (B,D,F,H) toward LPS and its modulation by preconditioning with Vitamin D3 (A,B) or DHA (C,D) or
post-hoc (subsequent to LPS) stimulation with Vitamin D3 (E,F) or DHA (G,H). Asterisks indicate significant differences to the LPS induced response. Results are
presented as averages ±SD from triplicate determinations. **p < 0.01, ****p < 0.0001 (adjusted p-values).
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FIGURE 2 | (A–H) TGFβ response of J774 (A,C,E,G) and HepG2 (B,D,F,H) toward LPS and its modulation by preconditioning with Vitamin D3 (A,B) or DHA (C,D) or
post-hoc (subsequent to LPS) stimulation with Vitamin D3 (E,F) or DHA (G,H). Asterisks indicate significant differences to the LPS induced response. Results are
presented as averages ±SD from triplicate determinations. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.0001 (adjusted p-values).
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FIGURE 3 | (A–H) TNFα and TGFβ response of J774 (A,C,E,G) and HepG2 (B,D,F,H) toward LPS and its modulation by preconditioning with FFA (A,B,E,F) or
post-hoc (subsequent to LPS) stimulation with FFA (C,D,G,H). Asterisks indicate significant differences to the LPS induced response. Results are presented as
averages ±SD from triplicate determinations. *p < 0.05, ***p < 0.005, ****p < 0.0001 (adjusted p-values).
product is involved in the breakdown of fatty acids. LPS-induced
stimulation of PPARα mRNA was very low, contrasting with the
robust increase of Srepb-1c mRNA. High PPARα mRNA was
achieved in conditions of preconditioning with Vitamin D3 for 1
day prior to LPS stimulation of J774, whereas this required 5 days
preincubation for HepG2 (Figures 5A,B). There was a notable
delay in PPARα mRNA response in HepG2 cells preconditioned
with Vitamin D3 (Figure 5B). A dose dependent response in
PPARα mRNA expression is recorded when stimulating J774
or HepG2 with LPS and subsequently with Vitamin D3 or
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FIGURE 4 | (A–H) qPCR analysis of J774 (A,C,E,G) and HepG2 (B,D,F,H) for Srebp-1c mRNA expression induced by LPS and modulated by preconditioning with
Vitamin D3 (A,B) or DHA (C,D) or post-hoc (subsequent to LPS) stimulation with Vitamin D3 (E,F) or DHA (G,H). Triplicate data were averaged, normalized to GAPDH
mRNA abundance and expressed in relation to baseline Srebp-1c mRNA expression. ap < 0.0001 compared to LPS, bp < 0.0001 compared to 1 day precond, cp <
0.002 compared to 1 day post-hoc stimulation (adjusted p-values).
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FIGURE 5 | (A–H) qPCR analysis of J774 (A,C,E,G) and HepG2 (B,D,F,H) for PPARα mRNA expression induced by LPS and modulated by preconditioning with
Vitamin D (A,B) or DHA (C,D) or post-hoc (subsequent to LPS) stimulation with Vitamin D3(E,F) or DHA (G,H). Triplicate data were averaged, normalized to GAPDH
mRNA abundance and expressed in relation to baseline PPARα mRNA expression. ap < 0.0001 compared to LPS, bp < 0.0001 compared to day 1, cp < 0.05
compared to day 1, dp < 0.05 compared to LPS, ep < 0.005 compared to LPS, fp < 0.001 compared to LPS, gp < 0.0005 compared to LPS (adjusted p-values).
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 June 2016 | Volume 4 | Article 61
Kheder et al. Beneficial Effect of Vitamin D3 and Docosahexaenoic Acid
DHA. The highest levels of PPARα mRNA were achieved at
5 days’ preincubation of J774 or HepG2 with 32 µg/ml DHA
(Figures 5C,D). After LPS stimulation, Vitamin D3 (4 µg/ml)
was able to increase PPARα mRNA expression significantly after
5 day’s treatment in J774 and HepG2 cells (Figures 5E,F). One
day’s post-hoc stimulation with DHA (after LPS stimulation) at
doses of 16 and 32 µg/ml was more efficient at increasing PPARα
mRNA in J774 than in HepG2 (Figures 5G,H).
The sole addition of FFA without LPS led to significantly
increased levels of Srebp-1c mRNA expression at 5 days’
stimulation compared to 1 day stimulation of J774 cells. FFA
at 30 mM increased Srepb-1c mRNA compared to LPS-induced
expression significantly when added for 5 days to J774 culture
prior to LPS stimulation (Figure 6A). While FFA at 30 mM
significantly increased Srebp-1c mRNA at 5 days’ stimulation
compared to the shorter incubation period of 1 day, additional
stimulation with LPS did not further increase Srebp-1c mRNA in
HepG2 cells (Figure 6B). Prior stimulation with LPS of J774 and
addition of FFA for 1 and 5 days significantly increased Srebp-
1c mRNA (Figure 6C). HepG2 cells showed an inconsistent
pattern of changes in Srebp-1c mRNA in response to LPS and
subsequent stimulation with FFA at 15 and 30 mM (Figure 6D).
FFA given for 1 and 5 days had a significant role in increasing
PPARα mRNA levels. Subsequent LPS stimulation decreased this
effect (Figure 6E). HepG2 cells showed an inconsistent pattern
of changes in PPARα mRNA in response to FFA and subsequent
stimulation with LPS (Figure 6F). Subsequent stimulation of
J774 with FFA after 4 h LPS led to modulation of PPARα mRNA
(Figure 6G); a clear reduction in PPARα mRNA was observed
in HepG2 cells exposed to 15mM FFA after LPS stimulation
(Figure 6H).
DISCUSSION
Endotoxemia is an important factor in the progression from
uncomplicated NAFLD to NASH (Finelli and Tarantino, 2014),
which carries the risk of developing cirrhosis. This study analyses
in parallel two TLR4 positive cell types of relevance to the
liver, the macrophage and hepatocyte, for their regulation of
inflammatory, fibrotic, and steatotic reactants when stimulated
with Vitamin D3 or DHA. These are dietary immune modulators
(Simopoulos, 2002; Prietl et al., 2013) whose adjuvant clinical
utility is beginning to be widely studied in preclinical and
clinical studies. The interest of this study lay in investigating
a qualitative difference in ameliorating the effect of endotoxin
if Vitamin D3 or DHA were present prior to this stimulus or
available shortly after. This might give an indication whether
constant dietary admixture is recommendable or whether doses
of treatment after LPS stimulus were effective. TNFα is a
key factor in the development of NAFLD and NASH in both
humans and animals (Braunersreuther et al., 2012). Hasegawa
et al. showed that TGFβ1 levels were increased in patients
with NASH as compared to patients with hepatic steatosis
(Hasegawa et al., 2001). Macrophages determine progression
of inflammation. This is because activation of macrophages
in liver leads to production of inflammatory mediators such
as TNF, Interleukin-1 and reactive oxygen species in NASH.
These inflammatory mediators further stimulate hepatocytes and
hepatic satellite cells to induce hepatocyte steatosis and fibrosis.
Macrophages encourage development of steatohepatitis because
of the interaction of chemokine-chemokine receptors on liver
cells and Kupffer cells (Miura et al., 2012). Steatosis, liver injury
and proinflammatory monocyte infiltration was reduced in vivo
as a result of depletion of Kupffer cells (Tosello-Trampont et al.,
2012).
This study finds that preconditioning with Vitamin D3 or
DHA prior to LPS stimulation or incubation following LPS
stimulation (“post-hoc”) decreased TNFα and TGFβ production
of J774 and of HepG2 significantly. Vitamin D3 and DHA
signal via distinct receptors (VDR and GPR120) but affect TLR4
mediated signaling effects in a similar manner, whether allowing
cells to adapt to the presence of Vitamin D3 or DHA prior to LPS
stimulation or treating the inflammatory state of HepG2 or J774
induced by LPS with Vitamin D3 or DHA subsequently.
Stimulation with obesity relevant FFA elicits elevated levels
of inflammatory cytokines in HepG2 and J774. The use of FFA
allowed consideration of development of tolerance in our system;
because FFA bind to TLR4 as endogenous DAMP, it is possible
that there is dampening of LPS mediated effects on subsequent
challenge or, vice versa, dampening of FFA effect because of
prior TLR4 engagement with LPS. In our study, there might be
evidence of tolerance development when stimulating J774 with
LPS, then subsequently with FFA for 1 day, because the elicited
TNFα response compared to that of FFA stimulation alone and
was half that achieved by LPS stimulation alone (Figure 3C). This
was not observed for HepG2.
Vitamin D3 and DHA efficiently downregulated LPS-induced
Srebp-1c mRNA expression in J774 and HepG2 cells regardless
of the timing of their addition, whether Vitamin D3 and DHA
were present before (preconditioning) or after (post-hoc) LPS
stimulation. The translation product of Srebp-1c mRNA is
involved in increasing cholesterol biosynthesis as part of an acute
phase reaction (Diomede et al., 2000). PPARα mRNA expression
showed an inverse pattern to that observed for Srebp-1c mRNA,
with regard to LPS-induced regulation and modulation by
Vitamin D3 and DHA. Our data suggest that qPCR can detect a
high ratio of Srebp-1c/PPARα in LPS-stimulatedHepG2 and J774
which is viewed as unfavorable in the obese (Pettinelli et al., 2009)
and is provoked by the addition of FFA in our study. Hepatic
Srebp-1c mRNA levels were significantly elevated, while hepatic
PPARα mRNA levels were significantly lower in obese patients
undergoing bariatric surgery compared to non-obese patients
undergoing cholecystectomy (Pettinelli et al., 2009). Relevant to
our study, these obese patients with NAFLD had significantly
lower DHA in liver total lipids compared to their study controls
(Pettinelli et al., 2009).
Taken together, Vitamin D3 and DHA exerted beneficial
effects in the context of endotoxin stimulation by reducing TNFα
and TGFβ proteins, and Srebp-1c mRNA, whilst increasing
PPARα mRNA. The translation products of Srebp-1c and
PPARα mRNA (which were not measured) are involved in
cholesterol biosynthesis and triglyceride turnover, respectively.
Macrophage responses are skewed toward a phenotype that
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FIGURE 6 | (A–H) qPCR analysis of J774 (A,C,E,G) and HepG2 (B,D,F,H) for Srebp-1c (A–D) and PPARα (E–H) mRNA expression induced by LPS and modulated
by preconditioning with FFA (A–D) or post-hoc (subsequent to LPS) stimulation with FFA (E–H). Triplicate data were averaged, normalized to GAPDH mRNA
abundance and expressed in relation to baseline Srebp-1c or PPARα mRNA expression. ap < 0.0001 compared to LPS, bp < 0.0001 compared to day 1,
cp < 0.001 compared to LPS, dp < 0.005 compared to LPS, ep < 0.005 compared to day 1, fp < 0.002 compared to LPS (adjusted p-values).
produces less proinflammatory TNFα and profibrotic TGFβ,
thereby is less able to support NAFLD development and
progression to NASH (Dey et al., 2014). Both, lipid metabolism
and inflammation are relevant in the development of insulin
resistance (Glass and Olefsky, 2012). Our data lend support
to both, curative and preventative dietary regimes involving
Vitamin D3 or DHA to quench the detrimental effects of low
grade endotoxemia. In vivo studies are needed next to address the
efficacy of dietary supplementation with an immune modulator
in enhancing the outcome from NAFLD. One recent clinical
trial of supplementation with Vitamin D3 showed significant
improvement in some serum markers of inflammation, but
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a greater observation time (>4 months) was likely to be
necessary to observe amelioration in transaminase levels and
ultrasonographic grades of NAFLD (Sharifi et al., 2014). A meta-
analysis of treatments of patients with NAFLD (for a median
duration of 6 months) with supplements of omega 3 fatty acids
showed significant ultrasonographic improvement of steatosis,
likely involving a reversal of the Srebp-1c/PPARα ratio (Parker
et al., 2012).
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